Aligos Therapeutics Inc (ALGS) earnings · rev $2.2M
These earnings events as JSON? API free 100/dayAligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
This ALGS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ALGS revenue for 2025-12-31 was $2.2M. Net income was -$24.2M. Revenue was down 39.5% from 2024-12-31 to 2025-12-31. ALGS currently screens at market cap $44.1M.
When the next ALGS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 39.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ALGS research stays on the stock page; the tape stays on the quote page.
ALGS earnings FAQ
What are ALGS's latest revenue and net income?
Latest cached Aligos Therapeutics Inc (ALGS) revenue for Dec 31, 2025 was $2.2M. Net income was -$24.2M. Statements: https://lician.com/financials/algs
What is ALGS's latest diluted EPS?
Latest cached Aligos Therapeutics Inc (ALGS) diluted EPS for Dec 31, 2025 was -$2.45.
What period does the latest ALGS earnings print cover?
The latest cached Aligos Therapeutics Inc (ALGS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ALGS revenue change from the prior cached period?
Cached Aligos Therapeutics Inc (ALGS) revenue was down 39.5% from $3.6M (Dec 31, 2024) to $2.2M (Dec 31, 2025). Statements: https://lician.com/financials/algs
Where are ALGS earnings listed?
Cached earnings facts for Aligos Therapeutics Inc (ALGS) are listed at https://lician.com/earnings/algs. Statements: https://lician.com/financials/algs
Not investment advice.